Introduction
Chrysotherapy, the use of gold formulations in medicine, primarily revolves around their use in the treatment of rheumatoid arthritis [1, 2] . Gold compounds belong to the disease modifying anti-rheumatic drug (DMARD) class of anti-arthritic agents and are known to halt the progression of the disease and to ease clinical manifestations. There are two classes of gold drugs with the first comprising, typically, polymeric, charged and water soluble gold(I) thiolates, with Myocrisin® (sodium gold(I) thiomalate) being a prominent example, Fig. 1(a) . By contrast, the second class of compound is monomeric, neutral and lipophilic, with Auranofin® (triethylphosphinegold(I) tetraacetylthioglucose) being the only clinically employed example, Fig. 1(b) .
While work on anti-arthritic activity of gold compounds continues [3] , most recent attention in developing molecular gold compounds for therapeutics revolves around their potential as anti-tumour agents [1, [4] [5] [6] [7] [8] . Links between anti-arthritic and anti-cancer activities relate to two clinical observations [9] [10] [11] , namely i) patients with rheumatoid arthritis and undergoing chrysotherapy are at a lower risk of developing cancer, and ii) anti-inflammatory drugs such as 6-mercaptopurine also display an anti-tumour activity. Early studies relating to anti-tumour potential indicated that gold(I) thiolates were generally inactive but that compounds related to Auranofin® demonstrated potential and, accordingly, significant early work focussed on developing phosphinegold(I) thiolates as anti-tumour agents [5] . While investigations continue with this class of compound [12, 13] , along with organometallic gold(I) derivatives, i.e. carbenes [14] [15] [16] [17] and alkynyl species [18, 19] , it is likely that most recent attention is directed towards developing gold(III) anti-tumour agents.
Motivated by the isoelectronic relationship between gold(III) and platinum(II), and the well-known anti-cancer drugs containing the latter element [20] , such as cisplatin (cis-diamminedichloroplatinum), gold(III) compounds also attracted early attention but the investigated derivatives were often reduced in vivo. More recently, with tailored ligand donor sets, gold(III) compounds, often featuring an Au\C bond, proved stable in the reducing mammalian environment and demonstrated exciting potential as anti-tumour drugs [21] [22] [23] [24] [25] [26] .
In the present contribution, building upon earlier work on phosphinegold(I) thiolates, e.g. 6-mercaptopurinates [27] , 2-mercaptocarboxylates [28] , and dithiocarbamates and xanthates [29] , investigations of the cytotoxicity profiles against the colon cancer HT-29 cancer cell line, a cancer of particular relevance to Asian populations, of a series of triphenylphosphinegold(I) carbonimidothioates are reported, see Fig. 2 for chemical structures. A particular motivation for the present study was the recently reported cytotoxicity, including against HT-29, exhibited by related platinum(II) carbonimidothioates [30] .
Colon carcinoma is the third leading cause of death from cancer [31] and adding to the therapeutic challenge is the observation that the occurrence of synchronous colorectal cancers has risen globally [32] . While traditional chemotherapy has improved outcomes for patients with advanced colorectal cancer, the efficacy of these chemical agents is still limited and chemo-resistance remains a major problem. Thus, the elucidation of the underlying mechanisms associated with the disease would improve the prognosis [33] .
HT-29 cells derived from a human colon adenocarcinoma were first established in culture by Fogh [34] and have been widely used as a cultured epithelial cell model for the study of a variety of plasma membrane receptors including aα-adrenergic receptors [35, 36] , insulin receptors [37] and vaso-active intestinal peptides [38, 39] . HT-29 cells share a common trait with other cancer cells in that glucose metabolism, culminating in lactic acid production, is impressively high [40] . A metabolic feature of HT-29 cells which may distinguish them from other cancer cells is that the removal of glucose from the culture media does not result in the death of all cells. Thus, a subpopulation of HT-29 cells can be maintained in permanent culture without glucose [41, 42] .
The human colon is particularly sensitive to stress because of the close distribution of noradrenergic fibres to its basement lamina [43] and colorectal cancer cells are known to express adrenergic receptors [44] . In recent studies, mouse model experiments showed that psychological stress was found to reduce the anti-tumour effects of chemotherapeutic drugs [45] . Recently, multidrug resistance was found to be induced by adrenaline in HT-29 cells by the upregulation of ABCB1 gene expression [44] . Despite the HT-29 cell line having numerous chromosomal aberrations, it exhibits significant genomic stability during passage in culture [46] . Finally, recent studies revealed that adrenaline could increase the cell proliferation and induce the cisplatin-resistance in HT-29 cells by the activation of the NFκB pathway and subsequent induction of microRNA-55 (miR-155) [47] , indicating that screening of novel agents is urgently needed to combat this disease.
Herein, the determination of selected biological effects in human HT-29 colon cells, resulting from the treatment of different gold compounds, is reported. The highly transformed HT-29 colon adenocarcinoma cell line as a model of late cancer stage was employed in the present study. Parameters of proliferation and cell viability were determined to assess time and concentration dependencies. To gain insight into the mechanism of action of the investigated compounds, studies of human apoptosis PCR-array analysis, caspase activities, DNA fragmentation, cell apoptotic assays, intracellular reactive oxygen species (ROS) measurements and human topoisomerase I inhibition tests were performed. H} NMR spectra were recorded in CDCl 3 solution on the same instrument at 25°C but the chemical shifts were recorded relative to 85% aqueous H 3 PO 4 as external reference; abbreviations for NMR assignments: s, singlet; d, doublet; t, triplet; q, quartet; sept, septet; and m, multiplet. Fig. 3 shows the numbering scheme adopted for the NMR spectra. IR spectra were obtained as KBr pellets on a Perkin Elmer RX1 FTIR spectrophotometer. Elemental analyses were performed on a Perkin Elmer PE 2400 CHN Elemental Analyser. Melting points were determined on a Krüss KSP1N melting point apparatus.
Experimental

Synthesis
All reactions were carried out under ambient conditions. All chemicals and solvents were sourced commercially and used as received.
Thiocarbamides
The thiocarbamides, ROC(=S)N(H)Ph, for R = Me, Et and iPr, were prepared as described in the literature whereby the respective alcohol was reacted with PhN = C = S [48] . Using this procedure the following compounds were prepared. 
X-ray crystallography
Crystals of 3 suitable for X-ray diffraction were obtained by slow evaporation from its chloroform/hexane (2/1) solution held at room temperature. Crystal data for C 28 [50] unique data (Bruker SMART APEX-II CCD [51] using Mo Kα radiation so that θ max = 27.5°) = 11,595, no. of parameters = 599, R (8755 data with I ≥ 2σ(I)) = 0.039, wR (all data) = 0.078. The structure was solved by direct-methods (SHELXS97 [52] [53] and QMol [54] , respectively. DIAMOND [55] was employed for the crystal packing diagrams in the Supplementary materials.
Cell culture and inhibition of cell growth
Human HT-29 colon carcinoma cell line was obtained from ATCC: The Global Bioresource Center and maintained in culture as described by the provider. The cells were routinely grown in RPMI 1640 medium containing 10% foetal calf serum (FCS) and antibiotics at 37°C and 6% CO 2 . For evaluation of growth inhibition tests, the cells were seeded in 96-well plates (Techno Plastic Products, TPP, Plastik für die Zellkultur, Switzerland) and grown for 24 h in complete medium. The stock solutions of metal compounds were prepared by dissolving the compounds in 1 mL of DMSO to reach a concentration of 10 −2 M.
They were then diluted in RPMI medium and added to the wells (100 μL) to obtain a final concentration ranging between 0 and 80 μM. DMSO at comparable concentrations did not show any effects on cell cytotoxicity. Stock solutions of the compounds were diluted directly in culture medium to the required concentration and added to the cell culture. After 24 h incubation at 37°C, 20 μL of a solution of MTT (3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide) in PBS (2 mg mL − 1 ) was added to each well, and the plates were then incubated for 2 h at 37°C. The medium was then aspirated and DMSO (100 μL) was added to dissolve the precipitate. The absorbance of each well was measured at 580 nm using a 96-well microplate reader and compared to the values of control cells incubated without test compound. The IC 50 values for the inhibition of cell growth were determined by fitting the plot of the percentage of surviving cells against the drug concentration using a sigmoidal function (Origin v7.5).
Extraction of RNA, and RT 2 Profiler PCR microarray
Total RNA was extracted from cultured HT-29 cells using a highpurity RNeasy Mini Kit (Qiagen, USA). The real-time PCR for microarray assay was performed using the RT Gene expression was compared according to the CT value.
Caspase activity (caspases 3, 7, 8, 9 and 10)
Caspase activity was assayed by measuring the light intensity using a kit (Caspase Assay, Milipore) and a luminometer (Perkin Elmer HTS 7000, France). Briefly, cells were cultured in 96-well plates in a final volume of 200 μL following the manufacturer's protocols (caspase 3/7: http://www.millipore.com/catalogue/item/apt423; 8: …/apt408; 9: …/ apt409; 10: …/apt174). Then 50 μL caspase reaction buffer was added and incubated at room temperature for 1 h before measurement. twice before transferring to a microcentrifuge tube. The cells were centrifuged at 1000 g for 10 min. Subsequently, the cells were suspended in 100 μL 1× PBS. Then, a 5 mg/mL acridine orange (AO) (Sigma) and propidium iodide (PI) (Sigma) mixture was added to the cells at 1:1 ratio for staining. This was followed by chilling on ice for 10 min. The mixture (20 μL) was aliquoted onto a slide and covered with a cover slip and viewed under an Olympus BX-51 fluorescence microscope. Images were captured by an attached Olympus CMAD-2 camera. The mode of cell death was then determined.
Human topoisomerase I inhibition assay
The human DNA topoisomerase I inhibitory activity was determined by measuring the relaxation of supercoiled plasmid DNA pBR 322. Each reaction mixture contained 10 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM phenylmethylsulfonyl fluoride, α-toluenesulfonyl fluoride, PMSF, and 1 mM 2-mercaptoethanol, 0.25 μg plasmid DNA pBR 322, 1 unit of human DNA topoisomerase I, and the test compound (dissolved in dimethylformamide (DMF)) at a specified concentration. The total volume of each reaction mixture was 20 μL and these mixtures were prepared on ice. Upon enzyme addition, reaction mixtures were incubated at 37°C for 30 min. The reactions were terminated by the addition of 2 μL of 10 % SDS, and then followed by 3 μL of dye solution comprising 0.02% bromophenol blue and 50% glycerol. SDS is required to denature topoisomerase I, preventing further functional enzymatic activity. Each mixture was applied to 1.2 % agarose gel and underwent electrophoresis for 5 h at 33 V with running buffer of Tris-acetate EDTA, TAE. The gel was stained, destained and photographed under UV light using a Syngene Bio Imaging system and the digital image was viewed with Gene Flash software.
Intracellular ROS measurements
5-(and-6)-Carboxy-2′,7′-dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA) (Sigma, USA) was used to detect intracellular ROS according to the manufacturer's instructions. For ROS quantification, cells were seeded in 96-well black plates (Greiner Bio-One, France) and treated with the trial compound (dissolved in 1% DMSO) at the indicated IC 50 concentrations for 24 h. Afterwards, cells were washed with PBS (phosphate buffeted saline) and incubated with 10 μM carboxy H2DCFDA in DPBS (Dulbecco's phosphate buffeted saline) for 1 h. Cells were then washed and fluorescence was measured by a plate reader (Perkin Elmer, France) with an excitation wavelength of 485 nm and an emission wavelength of 535 nm.
Nucleolytic study
Reagents were used as supplied. The pBR 322, gene ruler 1 kb DNA ladder, ethidium bromide, loading buffer, Tris, and agarose were bought from BioSyn Tech (Fermentas). All solutions for DNA experiments were prepared with ultra-pure water from an Elga PURELAB ULTRA Bioscience water purification system with UV light accessory. The Tris-NaCl buffer was prepared using ultra-pure water. The TrisNaCl buffer contained 5 mM Tris and 50 mM NaCl. The pH of the buffer solution was adjusted to pH 7.2 by addition of concentrated hydrochloric acid or sodium hydroxide. All stock solutions of buffers were autoclaved at 121°C. Agarose gel electrophoresis experiments were carried out on supercoiled plasmid DNA pBR322 (4.4 kb) using a horizontal gel system. For the cleavage studies, each 20 μL sample consisted of the compound dissolved in a certain amount of 1% DMF, DNA, and the required volume of additional buffer. All samples were incubated in the dark in an incubator at a temperature of 37°C. Each reaction mixture was prepared by adding: 1 μL of compound (vary stock concentration) to 0.5 μL of supercoiled plasmid DNA pBR322 (0.5 μg/μL) and Tris-NaCl buffer pH 7.2. T he resultant solution was made up to 20 μL with an additional buffer solution. All the reaction mixtures were incubated at 37°C for 24 h. After that, 3 μL of 6× loading buffer was added to 20 μL of the given reaction mixture and each electrophoresis was performed at 80 V for 90 min in TAE buffer, pH 8.1, using 1.5% agarose gel. After electrophoresis, the agarose gel was stained with ethidium bromide (EB) solution (0.5 μg/mL).
Results and discussion
Synthesis and spectroscopic characterization
The Ph 3 PAu[SC(OR) = NC 6 H 5 ], R = Me (1), Et (2) and iPr (3), compounds were prepared in high yields via the metathetical reaction of Ph 3 PAuCl with the respective ROC(=S)N(H)Ph thiocarbamide. The compounds are air-and light-stable crystalline solids. The NMR spectra exhibited the anticipated characteristics with resonances being assigned based on literature precedents [56] . It was thought worthwhile to monitor the stability of 1-3 by a time-dependent 1 H NMR study. It was observed that the 1 H NMR spectra of freshly prepared solutions of each of 1-3 were indistinguishable from the spectra measured after three days and after one week. However, after one month standing evidence for dissociation of the compounds was found through the appearance of resonances due to the N-H proton of the original thiocarbamide. The IR spectra of the compounds were noteworthy for the absence of a broad absorption at ca 3200 cm −1 assigned to ν(N-H) in the thiocarbamide molecules, and the red shift of ca 100 cm −1 to lower wavenumber of the absorption due to ν(C = S) in the thiocarbamide consistent with the reduction of the double bond character of this bond upon complexation in 1-3. The compounds are soluble in chlorinated solvents, partially soluble in acetonitrile and DMSO, are sparingly soluble in alcohols, and insoluble in water.
Molecular structure
As illustrated in Fig. 4 , two independent molecules comprise the crystallographic asymmetric unit in 3 and selected geometric parameters for these are collected in Table 1 . The gold atom is in an essentially linear geometry defined by sulphur and phosphorus atoms. The Au\P bond length is shorter than the Au\S bond length, and the angle subtended at the gold atom deviates from 180°as discussed below. Comparing the S1\C1 and C1\N1 bond lengths of the carbonimidothioate ligand with those found in the uncoordinated molecule [48] , i.e. 1.6679(19) and 1.337(2) Å, respectively, confirms that the anion is functioning as a thiolate ligand towards gold. There is a systematic variation of angles around the quaternary C1/C11 atoms which follow the expected trends with the widest angle involving the larger sulphur atom and the doubly-bonded nitrogen atom, and the narrowest angle involving the two singly-bonded atoms. The orientation of the [ − SC(OiPr) = NPh] anion places the O1/O2 atom in close proximity to the Au1/Au2 atom, i.e. 3.106(3) and 2.909(3) Å, respectively, and this is likely responsible for the observed deviations from linearity. The overlay diagram shown in Fig. 5 indicates significant differences in molecular conformation for the independent molecules and some of these are reflected in the geometric parameters. Most notably, the O1 atom is 0.2 Å further away from the Au1 atom that the corresponding interaction between O11 and Au2, i.e. 3.106(3) cf. 2.909(3) Å. This feature explains the small elongation of the Au2\S2 bond, the greater deviation of the S2-Au2-P2 angle from linearity, and systematic variations in the angles around the S2 and C11 atoms compared to the equivalent parameters in the Au1-containing molecule. Further, there is a significant conformational difference between the molecules which is best quantified in the dihedral angle formed between the least-squares plane through the three ipso-carbon atoms of the phosphine ligand and that through the SC(= N)O chromophore. While this dihedral angle is close to perpendicular in the Au2-containing molecule, i.e. 87.66(18)°, it is somewhat splayed in the Au1-containing molecule, i.e. 75.78(16)°; similar trends are evident in the torsion angles listed in Table 1 . Minor differences in geometric parameters and conformation notwithstanding, to a first approximation, the molecular structure described here for 3, matches those reported previously for 1 [49] and 2 [57] .
The most noteworthy feature of the crystal packing is the presence of Au…π(arene) interactions occurring between the two molecules comprising the asymmetric unit. Interactions of this type have been recognised as being important in the supramolecular chemistry of gold compounds [58, 59] and in the present case, the distance between the Au2 atom and the ring centroid of the C21-C26 phosphine-bound phenyl ring is 3.85 Å with the angle of approach being 26.4°for symmetry operation −1 + x, y, z. These interactions combine with a number of edge-to-face C-H…π(arene) interactions to form supramolecular layers in the ac-plane, see Fig. S1 and geometric details in the Supplementary data. Connections between layers also involve edge-to-face C-H…π(arene) interactions as detailed in Fig. S2. 
Inhibition of HT-29 colon cancer cell growth
Compounds 1-3 were evaluated in vitro by testing for the inhibition of cell proliferation activity against human colon cancer cell lines (HT-29), using cisplatin as the positive control. The effects of the compounds on the growth of the selected cell lines were evaluated after 24 h and the obtained IC 50 values are listed in Table 2 . From these data it can be seen that 1-3 each promoted significant inhibition of cell growth and potency levels comparable or greater than exhibited by cisplatin. Compound 1 was the most active among the series, exhibiting potency about twice that of cisplatin. The substitution of the O-bound methyl group in 1 with ethyl (2) and isopropyl (3) resulted in a reduction of potency, with 3 being marginally more potent than 2. The viability of the HT-29 cells after treatment with 1-3 at different concentrations is plotted in Fig. 6 . Exposure to increasing concentrations of 1-3 resulted in a significant dose-dependent inhibition of cell growth. This cell mortality was triggered by apoptotic processes characterized by chromatin condensation and DNA fragmentation, as discussed below.
Membrane permeability study (AO/PI apoptotic cell study)
The evaluation of the membrane integrity of the HT-29 cells after treatment with the respective IC 50 dose of each compound was accomplished by staining with AO/PI as shown in Fig. 7 .
It has been reported that apoptotic cells exhibit increased plasma membrane permeability to certain fluorescent dyes [60, 61] . Acridine orange (AO) is a membrane-permeable, monovalent, cationic dye, which binds to nucleic acids. In cells, a low concentration of AO causes a green fluorescence, while at high concentrations a red fluorescence is apparent [62] . When viewed by fluorescence microscopy, cells with an intact membrane appear to have a bright-green nucleus while apoptotic cells exhibit a bright-green nucleus with condensation of chromatin (as dense-green areas). On the other hand, propidium iodide (PI) is impermeable to intact plasma membranes, but it easily penetrates the plasma membrane of dead or dying cells and intercalates with DNA or RNA producing a bright-red fluorescence [63] . Therefore, cells that have lost membrane integrity will show red staining throughout the cytoplasm and a halo of green staining on the cell surface (plasma membrane). Apoptosis can be characterized by nuclear condensation with cytoplasm alteration and nuclear fragmentation [64] . The AO/PI staining showed that majority of HT-29 cells underwent apoptosis after treatment with 1-3. The morphological characteristics include condensation of nuclear chromatin and cytoplasm, membrane blobbing and the formation of apoptotic bodies. The apoptotic bodies appear to be round or oval masses of cytoplasm, and smaller than the size of the cell of origin. Interestingly, some of the 2-and 3-treated cells exhibited enlargement of cell volume and formation of multinucleated cells. Further, most of the cells were clumped together in a few colonies (Fig. 7c, d) ; this phenomenon was not apparent for the cells treated with 1. The control cells appeared to be shiny, clear and healthy. A small number of necrotic cells with ruptured plasma membrane were observed (Fig. 7e) . Finally, the number of apoptotic cells for the 1-3-treated cells was significantly greater than for the cisplatin-treated cells.
Determination of mode of cell death (DNA fragmentation study)
One of the hallmarks of the terminal stages of apoptosis is the fragmentation of chromosomal DNA that proceeds in a two-step manner: the DNA is initially cleaved into 50-300 kb fragments and eventually into oligonucleosomal pieces [65, 66] . In this study, the confirmation of apoptosis-induced cell death of HT-29 cells after exposure to 1-3 is presented in Fig. 8 which shows DNA ladder fragmentation.
Analysis of apoptotic pathway (PCR array study, caspase activity and measurement of reactive oxygen species (ROS) production)
In general, the apoptotic process can be divided into two categories, i) the intrinsic mitochondrial-mediated pathway activated by signals emanating from cellular damage sensors or other types of severe cell stress, and ii) the extrinsic apoptotic pathway initiated by ligand engagement of cell surface receptors such as CD95, APO-1, FAs and TNF receptors [67, 68] . The first intrinsic pathway involves the release of pro-apoptotic proteins from mitochondrial intermembrane space that in turn activate caspase proteases. Other than that, proteins of the BCL-2 family, which comprise pro-apoptotic (e.g. BAX, BAK, BNIP3) as well as anti-apoptotic (e.g. CL2, BCL-xL) members, are major regulators of the intrinsic pathway as they form homo-and hetero-oligomers which act directly at the outer mitochondrial membrane. The ratio of pro-to anti-apoptotic oligomers has been suggested to play an important role in determining cell death [69] [70] [71] . Although it is well established that many organelles, such as mitochondria, endoplasmic reticulum, Golgi apparatus, and lysosomes contribute to apoptosis, the majority of research thus far has focused on the role of mitochondria [72] . Mitochondria play a pivotal role in apoptosis by coordinating caspase activation through the release of apoptogenic factors such as the cytochrome c [73] . In metal-induced apoptosis, it is thought that the mitochondria are most pertinent in mediating apoptosis via metal-induced reactive oxygen species [74] . Although divergent with respect to induction, extrinsic and intrinsic apoptotic pathways tend to converge at later stages.
In this study, investigations into the mechanisms of 1-3-induced HT-29 cell death in vitro have been conducted. The results clearly indicate that the gold compounds trigger different levels of anti/pro-apoptotic gene expression. This work provides evidence that the cytotoxicity of 1-3 is related to the induction of a p53/p73-dependent activation of the mitochondrial pathway of apoptosis, demonstrating the anticancer properties of 1-3. Interestingly, the apoptosis PCR array analysis demonstrated that 1-3-induced apoptosis involved both intrinsic and extrinsic pathways mediated by different kinds of apoptosis-inducing factors. The three different proposed apoptotic pathways induced by 1-3 are shown in Fig. 9 .
Many cytotoxic metal complexes target DNA by binding it and inducing cell death through disruption of the cell cycle or by strand scission [75] . As such, studies on the aqueous chemistry of coordination compounds, their binding to DNA and their nucleolytic properties are of fundamental importance. The effect of varying the concentration of compounds 1-3 was investigated over the range 1-80 μM in Tris-NaCl buffer (TN buffer), (5 mM Tris; 50 mM NaCl) at pH 7.2 with an incubation time of 24 h and an incubation temperature of 37°C in the presence of 0.5 μg plasmid DNA, pBR322. Interestingly, compounds 1-3 were found to induce DNA cleavage activity by converting most of the supercoiled DNA to nicked and linear DNA in increasing complex concentration from 1 to 80 μM (Fig. 10a-c, L3-8 ). This indicates that each of 1-3 possesses a high tendency to cause DNA damage.
Generally, all compounds possess a similar apoptotic pathway in which p53/p73 is activated when DNA repair systems are overburdened due to excessive DNA damage. The p53/p73 genes also act as an upstream inducer of apoptosis by activating the expression of genes encoding either MMP-inducing proteins of the BCL-2 family, such as BAX, BID, NOXA and PUMA, or other apoptotic and cell cycle regulators [76] [77] [78] . The up-regulation of the p53/p73 genes indicates that 1-3 could induce DNA damage in HT-29 cells and is consistent with the DNA fragmentation results discussed above (Fig. 8) . Curiously, gene expression of p53 and its binding protein were found only in cases when treatment was with 2 and 3. Compound 1 was found to trigger the gene expression of p73 only, as seen by about a 3500-fold greater increase in TP73 expression compared to the untreated control cells (Table 3) .
The p73 gene is one of the two homologues of the tumour suppressor p53 and, as a result of differential promoter usage and alternative splicing, is expressed in different isoforms [79] . These isoforms contain a transactivation domain at their amino terminal ends, collectively termed TAp73 which, like p53, has long been known to induce programmed cell death [80] . The induction of pro-apoptotic genes is likely to represent the underlying mechanism in both intrinsic and extrinsic apoptosis. Fundamentally, the expression of TAp73 is activated by E2F-1, transcription factor 1, and this appears to be required for E2F-1-induced apoptosis at least in some assay systems [81] [82] [83] [84] , strongly suggesting that TAp73 can physiologically contribute to programmed cell death. Moreover, the high expression of the BNIP3L gene, a cell death inducer, in 2-and 3-treatment (79.43-and 126.21-fold, respectively) is supportive evidence for the activation of the p53 gene. Generally, p53 can directly up-regulate the expression of BNIP3L, which is known to be highly induced in wild-type p53-expressing cells, due, in part, to sequestering of p53 and CBP (CREB-binding protein) to BNIP3L during hypoxia. In hypoxia-exposed cells, apoptosis is reduced with functional p53 following BNIP3L knockdown. Tumorigenicity of wild-type versus mutant p53-expressing tumours in vivo is also promoted by BNIP3L knockdown. Thus, BNIP3L, capable of attenuating tumorigenicity, mediates p53-dependent apoptosis under hypoxia, which provides a novel understanding of p53 in tumour suppression [85] .
The activation of p53/p73 genes leads to high expression of BAX and BCL-2-associated X protein. In short, mitochondrial membrane permeability is regulated through a family of proto-oncogenes. The BCL-2 family of proto-oncogenes comprises anti-apoptotic (BCL-2) or pro-apoptotic (BAD, BAX) [86] . Once activated, BAX is inserted into the mitochondrial membrane and increases membrane permeability, thereby promoting apoptosis [87] . The anti-apoptotic protein, BCL-2, inhibits the ability of BAX to increase membrane potential [88] . In the treated HT-29 cells, BCL-2 was down regulated (Table 3 ). The loss of mitochondrial transmembrane potential is likely to be the initial event leading to apoptosis [89] and results in dissipation of the mitochondrial inner membrane potential (ΔΨm), disruption of the outer mitochondrial membrane and subsequent release of proteins such as the cytochrome c from the intermembrane region [90] . Cytochrome c, which binds to apoptotic activating factor-1 (APAF-1), was also significantly expressed in HT-29 cells treated with 1-3 (Table 3) and is known to activate caspase-9 ( Fig. 11 ; Tables 3 and 4) leading in turn to the activation of caspase-3 ( Fig. 12; Tables 3 and 4) ; caspase-3 is the most potent effector caspase with many substrates [91, 92] . It is thought that mitochondrial-induced apoptosis may also involve a caspase-independent pathway. After an apoptotic stimulus, an increase in mitochondrial membrane potential allows for the release of apoptosis-inducing factor (AIF), which activates a DNase leading to apoptosis [93, 94] .
An inhibitory effect on BCL-2 expression in HT-29 cells was shown upon treatment with 1-3 complexes (Table 3) . As mentioned above, the BCL-2 family is crucial in determining cell fate in the apoptotic pathway as they influence mitochondrial membrane polarization and . The red colour is produced by the PI stain which penetrates the nuclear matter when the cell membrane integrity is disturbed. Cells with an intact membrane are stained green. Apoptotic cells are stained green with nuclei stained red, and contain multiple yellow/green dots of condensed nuclei. Necrotic cells were stained bright-red due to the influx of PI stain. In (a), the green arrow points to a healthy cell, the blue arrow points to an apoptotic cell with a fragmented nucleus and condensed chromatin, and the red arrow points to a necrotic cell. Magnification = 100×.
cleavage-mediated caspase activation, which are the ultimate effectors in apoptosis signalling. Although little is known about the transcriptional factors that control the expression of BCL-2-related proteins, NF-κB is a known transcriptional factor involved in their regulation. Moreover, diminished expression of BCL-2 has been observed in cell types undergoing apoptosis [93] [94] [95] . Over and above these considerations, the balance between BAX and BCL-2 is crucial to the sustenance of apoptosis in the intrinsic pathway [96] .
In the extrinsic pathway, apoptosis is mediated by death receptors. As an example, FAS interacts with the FAS receptor, leading to an activation of caspase-8 ( Fig. 13 ; Tables 3 and 4 ) and caspase-10 [97] . The strong homology between caspase-8 and caspase-10 may suggest that both enzymes share similar substrate specificity and biological function [98] . Furthermore, active caspase-8 and caspase-10 could directly cleave and activate downstream effector proteases, such as caspase-3, causing apoptosis [99, 100] . The present study showed that treatment of HT-29 cells with 1-3 increased FAS gene expression, Table 3 . It is Fig. 8 . Gel images of the DNA fragmentation analysis. The HT-29 cells were cultured for 24 h in DMEM control media, in the presence of 11.3 μM of 1 (L2), 17.0 μM 2 (L4) and 16.8 μM 3 (L6). DNA was extracted from the cultures and DNA fragmentation was evaluated using electrophoresis with 2% agarose gel. L1, L3 and L5 are 1 kb DNA ladders. Compounds 1-3 show the presence of fragmented ladders (indicated by arrows) which suggest the cell death by apoptosis. Fig. 9 . Proposed signalling pathway of apoptosis induced by 1, 2 and 3. known that in response to DNA damage, p53 activates genes such as BAX and FAS via an extrinsic pathway [101, 102] , Fig. 9 . As mentioned above p73 is an isoform of p53 and some of their target genes overlap [103] . In turn, caspase-8, caspase-9, caspase-10 and caspase-3 were activated with an increase in their enzymatic activities ( Figs. 11-13 ; Tables 4 and 5) . Surprisingly, 1 and 3 showed a significant enzymatic activity and gene expression level on caspase-10 (Tables 3 and 5 ) but, 2 did not. Caspase-10 is classified as an initiator caspase and it is reported to play an important role in maintaining homeostasis and in the immune response, especially through the apoptotic signal from FAS. Caspase-10 is also involved in the elimination of the T-cells which react to self-antigen. Therefore, the introduction of mutations in caspase-10 leads to a decrease in the sensitivity to FAS-or TRIL-mediated apoptosis, and causes autoimmune diseases [104] . For example, human immunodeficiency virus (HIV) appears to down-regulate the apoptosis induction pathway by the suppression of caspase-10 to propagate themselves in the host cells [105] .
It is possible that caspase-8 and caspase-10 also could cleave the BCL-2 family member Bid, a BH3 interacting domain death agonist, to truncated BID (tBID), which binds to proapoptotic protein BAX, resulting in ΔΨm disruption and the release of cytochrome c [98, 106] . BID is generally considered as a molecular linker bridging death receptor and mitochondria pathways [107] . The 1-3 compounds also induced an up-regulating effect on BID expression in HT-29 cells (Table 3) , which provides additional supporting evidence for the proposed apoptotic pathways.
Only 2 was shown to induce an up-regulating effect on TNF (tumour necrosis factor) and TNFR (tumour necrosis factor receptor) genes in HT-29 cells with 40.19-and 83.02-fold enhancement, respectively, compared with the untreated control cells (Table 3 ); 1 and 3 caused down regulation of these genes under the same experimental conditions. In addition to caspase activation, stimulated death receptors often result in the activation of other signalling pathways that play a significant role in apoptosis. Moreover, TNFR activation results in the initiation of the JNK/MAP kinase pathway leading to the phosphorylation of pro-and anti-apoptotic proteins and regulation of gene expression. The JNK pathway is implicated in inhibiting the anti-apoptotic factor BCL-2 and the phosphorylation of an essential transcription factor, c-JUN [108] . In addition, p38 MAPK was shown to have pro-apoptotic effects, whereas ERK (Extracellular Regulated Kinase) was shown to have anti-apoptotic effects [109, 110] . Thus, it is proposed that 2 also induces apoptotic activity through a JNK/MAP kinase pathway (Fig. 9) .
It was thought of interest to also determine whether the observed cytotoxicity of 1-3 was correlated with the generation of ROS. The production of cellular ROS (mainly H 2 O 2 ) was analysed using the fluorogenic freely permeable tracer DCFH-DA which is deacylated by intracellular esterases to the non-fluorescent compound, DCFH, and oxidized to the fluorescent compound, DCF, through the action of peroxides in the presence of ROS such as hydroxyl radical and, especially, hydrogen peroxide [111, 112] . In the presence of 1-3, cellular ROS generation exceeded about 5-fold that of the negative control (untreated cells), indicating that the trial compounds do induce significant H 2 O 2 generation (Fig. 14) . Many reports have showed that ROS generation may be either a cause or a consequence of the PTP opening and mitochondrial alterations in apoptosis [113, 114] . The mitochondria are a source of ROS and, simultaneously, a target of excessive ROS generation. Besides, excess ROS increases the mitochondrial membrane permeability and damages the respiratory chain resulting in increased ROS production [74] . The disruption in the mitochondrial membrane causes the release of cytochrome c from the mitochondria, which initiates events leading to apoptosis. Although the exact mechanism is undefined, ROS are thought to play a role in TNFR and FAS receptor-mediated apoptosis [115] .
Human topoisomerase I inhibition study
The investigation of small molecules with topoisomerase I (topo I) has gained recent prominence due to its potential in the development of anti-cancer agents. DNA topoisomerases are enzymes involved in the supercoiling of DNA and play important roles in many aspects of DNA processing including replication, transcription, recombination and chromosome segregation [116] . DNA topoisomerases are important enzymes in the nucleus that modify the topological state of DNA through the introduction of transient breaks in the phosphodiester backbone of the DNA [117] . These enzymes have been identified as important targets in cancer chemotherapy and microbial infections [118] . Topoisomerase I inhibitors are proven to possess a wide range of anti-tumour activities and are among the most widely used anti-cancer drugs clinically [119] [120] [121] [122] . Accordingly, it was thought worthwhile to evaluate the potential of 1-3 to inhibit topo I.
In the DNA relaxation assay employed herein, one unit of human topo I can completely convert all the supercoiled plasmid pBR322 (4.4 kb) to fully relaxed topoisomer, which is the completely unwound covalently bonded closed circular DNA (Fig. 15a-c, lane 4) . This is found in the slowest moving DNA band (labelled Form II) which contains the fully relaxed closed circular pBR322 and the originally present, small amount of nicked DNA [122] ; the difference in plasmid size may account for the inability to separate the fully relaxed pBR322 from the nicked pBR322. Incubating pBR322 with the highest concentrations of 1-3 (0.125 to 4.0 μM) resulted in no cleavage or unwinding of the DNA as the banding pattern is the same as the control (Fig. 15a-c, lane 3) . Compounds 2 and 3 exhibited a full inhibitory activity on topo I at the lowest concentration, 2 μM, and both compounds started to show topoisomers at 0.25 μM. By contrast, 1 showed the lowest inhibitory capability on topo I at double the concentration of other two compounds in achieving full inhibition on topo I activity (Fig. 15a-c, lanes 6-11) . No inhibitory activity of topo I was observed in the presence of 1-3 alone as the DNA bands are the same as those observed for DNA incubated only with topo I (data not shown). However, when pBR322 was incubated with human topo I, increasing concentrations of 1-3 lead to i) the reduction of the nicked band (containing nicked and fully relaxed DNA), and ii) to the formation of various faster moving bands of topoisomers with different degrees of relaxation. At 0.5 μM of 1-3, unchanged supercoiled DNA band starts to appear (Fig. 15a-c,  lane 8) . The appearance of slower moving bands of less relaxed topoisomers was observed with increasing concentrations of 1-3 ( Fig. 15a-c, lanes 6-11) . These results showed that 1-3 are able to inhibit the function of topo I by relaxing the supercoiled pBR322, and also show that the degree of inhibition is dependent on concentration. The above also indicates that 1-3 are topo I inhibitors and not topo I poisons, which prevent the nicked DNA from relegation.
As a preliminary investigation into the mechanism of topo I inhibition, three variations of mixing the DNA, topo I and the gold compound were explored. When incubating the topo I with each of 1-3 prior to the addition of DNA, there is extensive inhibition as a fastest wide band appears and this comprises supercoiled DNA and poorly relaxed DNA (Fig. 16a-c, lane 6) . The light bands of topoisomers with different degrees of relaxation can be observed in Fig. 16a-c . When the DNA was first incubated with the gold compound for 30 min before the addition of topo I or when the three components are mixed simultaneously, the fastest moving band is wider, thereby appearing to be nearer to the slowest moving band (Form II). These observed differences in inhibition of topo I suggest initial binding of the respective gold compound to either the topo I or the DNA to give rise to differences in the mode of action. Further investigations in mechanisms of topo I inhibition by 1-3 are underway.
Conclusions
Three Ph 3 PAu[SC(OR) = NPh], R = Me (1), Et (2) and iPr (3) exhibit significant cytotoxicity to the HT-29 cancer cell line with 1 being the most active of the series. The compounds uniformly induce apoptosis and the possible mechanisms have been elucidated: both extrinsic and intrinsic pathways have been demonstrated. Compound 1 activates the p73 gene, whereas each of 2 and 3 activates p53. Compound 2 causes apoptosis by an additional mechanism, namely the JNK/MAP pathway. 
